Ultrasonography.  2025 Jan;44(1):42-47. 10.14366/usg.24149.

Equity in breast cancer screening for Asian women with dense breasts through ultrasonography: lessons learned from Japanese mammography screening and the J-START trial

• Uematsu T

• KMID: 2563158
• DOI: http://doi.org/10.14366/usg.24149

Figure

• 

  Fig. 1. Equity versus equality in breast cancer screening.Breast cancer screening worldwide uses mammography uniformly (represented by the same step stool in the left diagram), but this method lacks sensitivity (depicted as the red fruit) for women with dense breasts, leading to unchanged mortality rates. To improve this, an approach focusing on equity in breast cancer screening suggests extra tests (symbolized by providing a higher step stool: adding a pink step stool) for these women, ensuring they receive adequate screening sensitivity, promoting fairness in healthcare outcomes.

Reference

References

1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74:229–263.

2. International Agency for Research on Cancer (IARC). Breast cancer screening. IARC handbooks of cancer prevention, Vol. 15 [Internet]. Lyon: IARC Press, 2016 [cited 2024 Aug 8]. Available from: https://publications.iarc.fr/Book-And-Report-Series/Iarc-Handbooks-Of-Cancer-Prevention/Breast-Cancer-Screening-2016.

3. Chen TH, Yen AM, Fann JC, Gordon P, Chen SL, Chiu SY, et al. Clarifying the debate on population-based screening for breast cancer with mammography: a systematic review of randomized controlled trials on mammography with Bayesian meta-analysis and causal model. Medicine (Baltimore). 2017; 96:e5684.

4. Uematsu T. Rethinking screening mammography in Japan: next-generation breast cancer screening through breast awareness and supplemental ultrasonography. Breast Cancer. 2024; 31:24–30.

5. Uematsu T, Izumori A, Moon WK. Overcoming the limitations of screening mammography in Japan and Korea: a paradigm shift to personalized breast cancer screening based on ultrasonography. Ultrasonography. 2023; 42:508–517.

6. Tabar L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011; 260:658–663.

7. Duffy SW, Tabar L, Yen AM, Dean PB, Smith RA, Jonsson H, et al. Beneficial effect of consecutive screening mammography examinations on mortality from breast cancer: a prospective study. Radiology. 2021; 299:541–547.

8. American College of Radiology. Talk to your doctor about your breast cancer risk by age 25 [Internet]. Reston, VA: American College of Radiology, 2024 [cited 2024 Aug 8]. Available from: https://www.acr.org/Practice-Management-Quality-Informatics/Practice-Toolkit/Patient-Resources/Mammography-Saves-Lives.

9. Plevritis SK, Munoz D, Kurian AW, Stout NK, Alagoz O, Near AM, et al. Association of screening and treatment with breast cancer mortality by molecular subtype in US women, 2000-2012. JAMA. 2018; 319:154–164.

10. Caswell-Jin JL, Sun LP, Munoz D, Lu Y, Li Y, Huang H, et al. Analysis of breast cancer mortality in the US-1975 to 2019. JAMA. 2024; 331:233–241.

11. Bahler C, Brungger B, Ulyte A, Schwenkglenks M, von Wyl V, Dressel H, et al. Temporal trends and regional disparities in cancer screening utilization: an observational Swiss claims-based study. BMC Public Health. 2021; 21:23.

12. Bulliard JL, De Landtsheer JP, Levi F. Results from the Swiss mammography screening pilot programme. Eur J Cancer. 2003; 39:1761–1769.

13. Woloshin S, Jorgensen KJ, Hwang S, Welch HG. The new USPSTF mammography recommendations: a dissenting view. N Engl J Med. 2023; 389:1061–1064.

14. Iwamoto T, Kumamaru H, Miyata H, Tomotaki A, Niikura N, Kawai M, et al. Distinct breast cancer characteristics between screen-and self-detected breast cancers recorded in the Japanese Breast Cancer Registry. Breast Cancer Res Treat. 2016; 156:485–494.

15. Uematsu T. Sensitivity and specificity of screening mammography without clinical breast examination among Japanese women aged 40-49 years: analysis of data from the J-START results. Breast Cancer. 2022; 29:928–931.

16. Moshina N, Sebuodegard S, Lee CI, Akslen LA, Tsuruda KM, Elmore JG, et al. Automated volumetric analysis of mammographic density in a screening setting: worse outcomes for women with dense breasts. Radiology. 2018; 288:343–352.

17. Nara M, Fujioka T, Mori M, Aruga T, Tateishi U. Prediction of breast cancer risk by automated volumetric breast density measurement. Jpn J Radiol. 2023; 41:54–62.

18. Department of Health and Human Services. Food and Drug Administration Mammography Quality Standards Act final rule [Internet]. Silver Spring, MD: Food and Drug Administration, 2023 [cited 2024 Aug 8]. Available from: https://public-inspection.federalregister.gov/2023-04550.pdf.

19. Mann RM, Athanasiou A, Baltzer PA, Camps-Herrero J, Clauser P, Fallenberg EM, et al. Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI). Eur Radiol. 2022; 32:4036–4045.

20. Ohuchi N, Suzuki A, Sobue T, Kawai M, Yamamoto S, Zheng YF, et al. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet. 2016; 387:341–348.

21. Harada-Shoji N, Suzuki A, Ishida T, Zheng YF, Narikawa-Shiono Y, Sato-Tadano A, et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2021; 4:e2121505.

22. Ray KM. Interval cancers in understanding screening outcomes. Radiol Clin North Am. 2024; 62:559–569.

23. Sprague BL, Ichikawa L, Eavey J, Lowry KP, Rauscher GH, O'Meara ES, et al. Performance of supplemental US screening in women with dense breasts and varying breast cancer risk: results from the Breast Cancer Surveillance Consortium. Radiology. 2024; 312:e232380.

24. Uematsu T. The need for supplemental breast cancer screening modalities: a perspective of population-based breast cancer screening programs in Japan. Breast Cancer. 2017; 24:26–31.

25. Uematsu T, Nakamura S, Ohuchi N. Do you know how to get the J-START quality assurance guideline? Breast Cancer. 2018; 25:375–376.

26. J-START quality assurance guideline for ultrasonography [Internet]. Tokyo: Japanese Breast Cancer Society, 2023 [cited 2024 Aug 8]. Available from: https://www.jbcs.gr.jp/modules/English/index.php?content_id=11.